About NextFerm
NextFerm is a company based in Yokneam Illit (Israel) founded in 2013.. NextFerm offers products and services including ProteVin™, Maximmune, AstaFerm®, NextFreeze™, and Biofuel. NextFerm operates in a competitive market with competitors including Nuevolution, Protalix BioTherapeutics, Lutris Pharma, Curesponse and Colbar LifeScience, among others.
- Headquarter Yokneam Illit, Israel
-
Sectors
HealthcareAgriculture
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Nextferm Technologies
-
Annual Revenue
$176.63 K (USD)-38.29as on Dec 31, 2024
-
Net Profit
$-5.4 M (USD)-25.43as on Dec 31, 2024
-
EBITDA
$-3.62 M (USD)5.73as on Dec 31, 2024
-
Latest Funding Round
$55.99 K (USD), Grant
Dec 31, 2019
-
Investors
European Union
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NextFerm
NextFerm offers a comprehensive portfolio of products and services, including ProteVin™, Maximmune, AstaFerm®, NextFreeze™, and Biofuel. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Fermented protein that enhances food flavor and nutritional value.
Fermentation-based product for immune support in nutrition.
Fermented ingredient used for health and food applications.
Technology for preserving food through fermentation methods.
Fermentation-derived biofuel for sustainable energy use.
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of NextFerm
- Total Funding Total Funding
- Total Rounds 2
- Last Round Grant — $55,993
-
First Round
First Round
(01 Sep 2019)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2019 | Amount | Grant - NextFerm | Valuation |
investors |
|
| Sep, 2019 | Amount | Grant - NextFerm | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in NextFerm
NextFerm has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union and EIC Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Founded Year | Domain | Location | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by NextFerm
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - NextFerm
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Nextferm Comparisons
Competitors of NextFerm
NextFerm operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nuevolution, Protalix BioTherapeutics, Lutris Pharma, Curesponse and Colbar LifeScience, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Drug treatments for oncology and chronic inflammatory diseases are developed.
|
|
| domain | founded_year | HQ Location |
Recombinant proteins are developed via a plant cell-based expression system.
|
|
| domain | founded_year | HQ Location |
Provider of anti-cancer therapy
|
|
| domain | founded_year | HQ Location |
Provider of a tissue culture system to analyze cancer growth and drug response
|
|
| domain | founded_year | HQ Location |
Collagen-based products for tissue regeneration and dental applications are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutic products for ENT disorders are developed via FoamOtic technology.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Nextferm
Frequently Asked Questions about NextFerm
When was NextFerm founded?
NextFerm was founded in 2013 and raised its 1st funding round 6 years after it was founded.
Where is NextFerm located?
NextFerm is headquartered in Yokneam Illit, Israel. It is registered at Yokneam Illit, North District, Israel.
What is the annual revenue of NextFerm?
Annual revenue of NextFerm is $176.63K as on Dec 31, 2024.
What does NextFerm do?
The company was founded in 2013 and is located in Yokneam Illit, Israel. Non-GMO proprietary technology is utilized to develop improved microorganisms, focusing on yeast strains. Operations target the fermented ingredients sector, with solutions intended for food, dietary supplements, brewing, and animal feeds. Development efforts emphasize natural, non-genetically modified approaches to enhance microbial performance in these markets.
Who are the top competitors of NextFerm?
NextFerm's top competitors include Protalix BioTherapeutics, Lutris Pharma and Minovia Therapeutics.
What products or services does NextFerm offer?
NextFerm offers ProteVin™, Maximmune, AstaFerm®, NextFreeze™, and Biofuel.
Who are NextFerm's investors?
NextFerm has 2 investors. Key investors include European Union, and EIC Fund.